Modeling based response guided therapy in subjects with recent hepatitis C infection.

Evan Gorstein1, Marianne Martinello2, Alexander Churkin3

  • 1The Program for Experimental and Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Medical Center, Maywood, IL, 60053, USA.

Antiviral Research
|June 28, 2020
PubMed
Summary

Mathematical modeling suggests that longer than six weeks of sofosbuvir (SOF) and ribavirin (R) therapy is needed for a sustained virologic response in recently infected hepatitis C virus (HCV) patients. Further research is required to validate response-guided therapy for recent HCV infection.